Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Pediatr Nephrol. 2020 Jun 15;35(11):2113–2120. doi: 10.1007/s00467-020-04622-3

Table 2.

Renal Scarring According to Treatment Group

Renal scarring Corticosteroid Treatment Group Placebo Treatment Group Absolute Difference in Risk in % (95% CI) P value

No. of children with renal scarring/total (%) Percentage points
Overall 12/123(9.8%) 22/131 (16.8%) 5.9% (−2.2, 14.1) 0.16a
Severe 0/123 (0%) 3/131 (2.3%) 2.3% (−0.3, 4.9) 0.25
a

Adjusted for duration of fever before presentation (our stratification variable) and age. Unadjusted p-value was 0.10